Pacific Biosciences of Californ (PACB) Financials

PACB Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 1.7 billion 1.0 billion
2023-12-31 1.7 billion 1.0 billion
2023-09-30 1.9 billion 1.1 billion
2023-06-30 1.8 billion 1.2 billion

PACB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -79.6 million 19.5 million
2023-12-31 -59.6 million 16.6 million
2023-09-30 -66.0 million 19.7 million
2023-06-30 -44.0 million 17.9 million

PACB Net Income

No data available :(

PACB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 561.9 million - 38.8 million
2023-12-31 631.7 million - 41.2 million
2023-09-30 767.8 million - 43.6 million
2023-06-30 829.9 million 891.8 million 45.8 million

PACB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 269.6 million
2023-12-31 267.1 million
2023-09-30 255.0 million
2023-06-30 250.1 million

PACB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 3.9 million 43.5 million 43.8 million -
2023-12-31 2.0 million 44.5 million 46.0 million -
2023-09-30 830000 47.5 million 43.4 million -
2023-06-30 2.3 million 46.2 million 42.5 million -

PACB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 38.8 million 38.2 million
2023-12-31 58.4 million 47.4 million
2023-09-30 55.7 million 37.8 million
2023-06-30 47.6 million 32.0 million

PACB

Price: $2.02

52 week price:
1.25
14.55

Payout Ratio Range:
-281.49%
-90.91%

Earnings Per Share: -1.21 USD

P/E Ratio: -5.11

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Volume: 5.8 million

Ebitda: -20.1 million

Market Capitalization: 584.2 million

Links: